BMI, Adiposity & Tirzepitide and HFpFF; BAV-0 and Aortic Stenosis; Infective Endocarditis and Mitral Valve Replacement
In this week’s View, Dr. Eagle looks at the SUMMIT trial and considers how body mass index (BMI) and central adiposity affect tirzepatide outcomes for heart failure with preserved ejection fraction (HFpEF). He then discusses bicuspid aortic valves type 0 (BAV-0) and its association with better long-term prognosis in patients with severe aortic stenosis (AS) undergoing tricuspid aortic valve replacement (TAVR). Finally, Dr. Eagle examines long-term risk of infective endocarditis and why it is significantly higher for mitral valve (MV) replacement versus repair. Subscribe to Eagle’s Eye View
--------
7:02
--------
7:02
The PREVENT Model & Risk Prediction; Carbohydrate Quality & Improved LV Structure; Radial Access for PCI & Lower Complication Rates
In this week’s View, Dr. Eagle looks at the PREVENT model and its ability to predict ten-year atherosclerotic cardiovascular disease risk in diverse populations. He then discusses higher carbohydrate quality and fiber-rich foods and their links to better cardiac structure and function. Finally, Dr. Eagle explores increased use of radial access for percutaneous coronary intervention to achieve lower complication rates. Subscribe to Eagle’s Eye View
--------
7:18
--------
7:18
AV after TTVR; Deep Learning in Automating Cardiac IMG; Survival Benefits Post-2018 Heart Transplantation Policy Change
In this week’s View, Dr. Eagle looks at predictors of high-grade atrioventricular block (AV) after transcatheter tricuspid valve replacement (TTVR). He then discusses the challenges and benefits of deep learning in automating cardiac imaging (IMG). Finally, Dr. Eagle explores higher survival benefits after the 2018 U.S. Heart Transplantation Allocation policy change. Subscribe to Eagle’s Eye View
--------
8:08
--------
8:08
Ischemic Preconditioning & Noncardiac Surgery; The Microaxial Flow Pump in STEMI-CS; DOACs After Strokes
In this week’s View, Dr. Eagle looks at whether ischemic preconditioning provides benefit in noncardiac surgery. He then discusses the benefits of the microaxial flow pump in STEMI-cardiogenic shock (CS) patients undergoing hemodynamic monitoring. Finally, Dr. Eagle explores starting direct oral anticoagulants (DOACs) early after stroke, and whether it lowers the risk of future strokes and hemorrhage. Subscribe to Eagle’s Eye View
--------
7:03
--------
7:03
Frailty Status and Mortality Risk in PCI; Delays in Treatment in STEMI; Arterial Events with Genetic-based Vascular Disease
In this week’s View, Dr. Eagle looks at frailty status and increased risk of mortality in patients who undergo percutaneous coronary intervention (PCI). He then discusses the timely treatment and delays in treatment of ST-segment elevation myocardial infarction (STEMI) that are associated with worse outcomes. Finally, Dr. Eagle explores new insights on arterial events associated with heritable thoracic aortic disease and the relative risk in patients with pathogenic variants, as well as the prevalence, characteristics, and clinical outcomes of arterial aneurysms in Loeys-Dietz Syndrome. Subscribe to Eagle’s Eye View
Sobre Eagle's Eye View: Your Weekly CV Update From ACC.org
The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
Brasil